In a distinct study by Arbadia et al. [51], diagnosis of prostate cancer was attempted not through the usual detection of PSA protein antigen, which suffers from low specificity, but through the PCA3 gene, a biomarker present in the urine of prostate cancer patients. The gene discussed is KLK3; the disease is prostate carcinoma.